California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The California Prehospital Antifibrinolytic Therapy (Cal-PAT) study seeks to evaluate the
safety and efficacy of Tranexamic Acid (TXA) use in the civilian prehospital and in hospital
setting in cases of traumatic hemorrhagic shock.